Hydroxyzine Hydrochloride

CHEMBL3186993 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
447.8 g/mol
LogP
Phase
4

This hydrochloride salt of hydroxyzine is the oral tablet and syrup form used to relieve anxiety, allergic itching, and tension. It has sedating effects through antihistamine and anticholinergic actions, making it useful for short-term anxiety management and preoperative sedation. It is considered non-habit-forming compared to many other anxiolytics.

Peso Molecular

447,8000 g/mol

TPSA

35,90 Ų

Áreas Terapêuticas

Mecanismo de Ação

Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cl.Cl.OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1

InChI

InChI=1S/C21H27ClN2O2.2ClH/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25;;/h1-9,21,25H,10-17H2;2*1H

Molecular Formula

C21H29Cl3N2O2

HBD / HBA

3 / 4

Ligações Rotacionáveis

8

Átomos Pesados

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This hydrochloride salt of hydroxyzine is the oral tablet and syrup form used to relieve anxiety, allergic itching, and tension. It has sedating effects through antihistamine and anticholinergic actions, making it useful for short-term anxiety management and preoperative sedation. It is considered non-habit-forming compared to many other anxiolytics.

Competitively blocks histamine H1 receptors on effector cells, preventing histamine-mediated vasodilation, increased vascular permeability, bronchoconstriction, and pruritus. First-generation agents also cross the blood-brain barrier, causing sedation.

Yes, Hydroxyzine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3186993. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 91513. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.